Neos Therapeutics Inc. (NEOS) stock skyrocketing in pre-market. Here’s to know why?
Neos Therapeutics Inc. (NASDAQ: NEOS) stock showed a rise of 1.72% in the last trading close, while NEOS stock price rises by 10.17% during pre-market.
Neos Therapeutics Inc. (NASDAQ: NEOS) stock showed a rise of 1.72% in the last trading close, while NEOS stock price rises by 10.17% during pre-market.
Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter
Immutep Limited (NASDAQ: IMMP) shares are trading down -26.19% at $4.2 at the time of writing after reporting that its Chinese partner, EOC Pharma will
Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical corporation focusing on the marketing of new drugs targeting critical medical needs, and Neos Therapeutics, Inc. (NASDAQ:
The global generics drug market continues to grow with the increasing demand for more medication. Drug manufacturers are continuously striving to meet the need for
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.